Arch Aesthetic Plast Surg.  2016 Feb;22(1):40-44. 10.14730/aaps.2016.22.1.40.

The Effectiveness of Ablative Fractional Carbon Dioxide Laser with Autologous Platelet Rich Plasma Combined Resurfacing for Hypertrophic Scar of the Shoulder

Affiliations
  • 1Department of Plastic and Reconstructive Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea. peunsoo@schmc.ac.kr
  • 2Department of Plastic and Reconstructive Surgery, Soonchunhyang University Seoul Hospital, Seoul, Korea.

Abstract

Laser treatment for scars has improved over the past three decades. Autologous platelet-rich plasma (PRP) derived from whole blood is immunologically inert and contains a proper ratio of growth factors and cytokines. Here we describe the case of a 29-year-old female patient with a hypertrophic scar on her right shoulder caused by an operation performed in 2012. The patient underwent 11 laser therapy sessions with a fractional carbon dioxide (CO2) ablative laser system (LineXel) and two PRP injections. Her scar was evaluated with the Vancouver Scar Scale (VSS), and the baseline and post-treatment scores were 11 and 3, respectively. After treatment, the dimensions and volume of the scar were diminished, and contour, texture, and pigmentation had also improved compared to baseline. The patient reported less pain, swelling, and pigmentation following PRP combination ablative laser therapy. This case provides further evidence of the potential benefits of PRP as an adjuvant to fractional laser in reducing hypertrophic scars.

Keyword

Hypertrophic scar; Fractional laser; Platelet-rich plasma

MeSH Terms

Adult
Blood Platelets*
Carbon Dioxide*
Carbon*
Cicatrix
Cicatrix, Hypertrophic*
Cytokines
Female
Humans
Intercellular Signaling Peptides and Proteins
Laser Therapy
Lasers, Gas*
Pigmentation
Platelet-Rich Plasma*
Shoulder*
Carbon
Carbon Dioxide
Cytokines
Intercellular Signaling Peptides and Proteins
Full Text Links
  • AAPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr